VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AAME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AAMEAtlantic American Corporation
$1.72$35M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAAMEFinancials

Atlantic American Corporation (AAME) Financials

30Y historyFree accessUpdated daily

Revenue growth accelerated to 20.8% in 2025Q3, though underwriting profitability remains inconsistent with combined ratios fluctuating between 92.4% and 106.6% over the last ten quarters.

AAME Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96Dec'95
Revenue208.22M188.23M186.79M187.85M199.55M195.35M198.18M185.55M181.11M166.08M165.94M166.32M165.37M139.83M118.33M106.89M102.71M99.73M122.97M125.36M121.98M125.78M111.3M170.25M163.31M152.26M124.32M106.07M101.22M99.07M51.67M
Revenue Growth %11.99%0.77%-0.56%-5.86%2.15%-1.43%6.8%2.45%9.05%0.08%-0.23%0.58%18.27%18.17%10.71%4.07%2.99%-18.9%-1.9%2.77%-3.02%13.01%-34.62%4.25%7.26%22.47%17.21%4.79%2.16%91.74%-69.1%
Medical Costs & Claims168.86M173.86M168.62M170.17M179.19M166.69M184.7M171.69M160.96M147.99M144.6M147.12M140.93M154.77M132.69M94.95M89.16M87.65M91.36M101.86M109.42M126.71M111.65M152.87M144.21M134.31M107.88M88M84.02M81.24M39.94M
Medical Cost Ratio %81.1%92.37%90.27%90.59%89.8%85.33%93.2%92.53%88.87%89.11%87.14%88.45%85.22%110.69%112.13%88.83%86.81%87.88%74.3%81.26%89.7%100.74%100.31%89.79%88.31%88.21%86.77%82.97%83.01%82%77.29%
Gross Profit39.36M14.37M18.17M17.68M20.36M28.66M13.48M13.86M20.15M18.08M21.34M19.2M24.44M-14.94M-14.35M11.94M13.55M12.09M31.61M23.49M12.56M-933K-345K17.38M19.09M17.95M16.45M18.06M17.2M17.83M11.73M
Gross Margin %18.9%7.63%9.73%9.41%10.2%14.67%6.8%7.47%11.13%10.89%12.86%11.55%14.78%-10.69%-12.13%11.17%13.19%12.12%25.7%18.74%10.3%-0.74%-0.31%10.21%11.69%11.79%13.23%17.03%16.99%18%22.71%
Gross Profit Growth %--20.93%2.75%-13.17%-28.95%112.67%-2.77%-31.22%11.45%-15.25%11.12%-21.43%263.56%-4.1%-220.26%-11.89%12.1%-61.77%34.54%87.07%1446.09%-170.43%-101.99%-8.99%6.36%9.16%-8.94%5.02%-3.56%51.99%-92.98%
Operating Expenses32.79M19.63M18.73M15.59M15.06M13.16M13.88M14.83M14.8M14.56M15.63M14.3M13.23M-20.02M-17.67M11.31M12.2M13.08M12.51M13.87M13.17M-8.62M-6.37M14.28M14.84M13.2M12.52M9.36M-58.12M10.02M8.65M
OpEx / Revenue %15.75%10.43%10.03%8.3%7.55%6.74%7.01%7.99%8.17%8.77%9.42%8.6%8%-14.32%-14.93%10.59%11.88%13.11%10.17%11.06%10.8%-6.86%-5.72%8.39%9.09%8.67%10.07%8.82%-57.42%10.11%16.74%
Depreciation & Amortization346K366K652K890K1M980K996K987K1.44M1.21M1.12M932K600K469K388K10.15M323K10.23M11.23M871K949K1.36M1.14M17.61M1.68M1.74M1.44M1.37M10.8M1.1M547K
Combined Ratio %96.85%102.8%100.3%98.88%97.34%92.06%100.21%100.52%97.04%97.88%96.56%97.05%93.22%96.37%97.2%99.42%98.69%100.99%84.47%92.32%100.5%93.89%94.59%98.18%97.4%96.88%96.85%91.79%25.59%92.11%94.03%
Operating Income6.57M-5.26M-565K2.1M5.3M15.5M-407K-971K5.36M3.52M5.71M4.9M11.21M5.08M3.31M621K1.35M-992K19.1M9.62M-614K7.69M6.02M3.1M4.25M4.76M3.92M8.7M75.31M7.82M3.08M
Operating Margin %3.15%-2.8%-0.3%1.12%2.66%7.94%-0.21%-0.52%2.96%2.12%3.44%2.95%6.78%3.63%2.8%0.58%1.31%-0.99%15.53%7.68%-0.5%6.11%5.41%1.82%2.6%3.12%3.15%8.21%74.41%7.89%5.97%
Operating Income Growth %--831.68%-126.96%-60.47%-65.8%3909.09%58.08%-118.13%51.99%-38.26%16.39%-56.24%120.5%53.3%433.82%-54%236.09%-105.19%98.44%1667.43%-107.98%27.7%94.07%-27.04%-10.58%21.26%-54.94%-88.44%863.72%153.4%-96.79%
EBITDA6.91M-4.9M87K2.99M6.3M16.48M589K16K6.79M4.73M6.83M5.84M11.81M5.55M3.7M10.78M1.67M9.24M30.32M10.49M335K9.05M7.16M20.71M5.93M6.5M5.36M10.07M86.11M8.92M3.63M
EBITDA Margin %3.32%-2.6%0.05%1.59%3.16%8.44%0.3%0.01%3.75%2.85%4.11%3.51%7.14%3.97%3.13%10.08%1.63%9.26%24.66%8.37%0.27%7.2%6.43%12.17%3.63%4.27%4.31%9.5%85.08%9%7.03%
Interest Expense3.15M3.42M3.27M1.95M1.39M1.61M2.13M2.04M1.72M1.56M1.43M1.61M1.9M2.63M2.6M2.61M2.76M3.3M4.16M4.61M3.61M3.07M3.12M2.56M3.23M4.41M2.82M2.15M2.9M3.29M2.46M
Non-Operating Income-3.15M-3.42M-3.27M-1.95M-1.39M-1.61M-2.13M-2.04M-1.72M-1.56M-1.43M-1.61M-1.9M-2.63M-2.6M-2.61M-2.76M-3.3M-4.16M-4.61M-3.61M298K-3.62M-2.56M-3.23M-4.41M-2.82M-2.15M72.42M-3.29M-2.46M
Pretax Income6.57M-5.26M-565K2.1M5.3M15.5M-407K-971K5.36M3.52M5.71M4.9M11.21M5.08M3.31M621K1.35M-992K19.1M9.62M-614K7.69M6.02M3.1M4.25M4.76M3.92M8.7M8.1M7.82M3.08M
Pretax Margin %3.15%-2.8%-0.3%1.12%2.66%7.94%-0.21%-0.52%2.96%2.12%3.44%2.95%6.78%3.63%2.8%0.58%1.31%-0.99%15.53%7.68%-0.5%6.11%5.41%1.82%2.6%3.12%3.15%8.21%8%7.89%5.97%
Income Tax1.46M-996K-394K571K1.02M3.33M-21K-267K828K888K1.32M474K184K646K25K-369K2.56M-526K7.51M2.46M-1.75M-149K-454K-498K656K1.12M-6.99M145K100K204K-34K
Effective Tax Rate %22.21%18.92%69.73%27.24%19.26%21.51%5.16%27.5%15.46%25.2%23.13%9.67%1.64%12.71%0.75%-59.42%189.41%53.02%39.34%25.54%284.36%-1.94%-7.54%-16.05%15.42%23.63%-178.17%1.67%1.23%2.61%-1.1%
Net Income5.11M-4.27M-171K1.52M4.28M12.17M-386K-704K4.53M2.64M4.39M4.43M11.02M4.44M3.29M990K-1.21M-3.88M7.25M8.94M-3.17M5.02M6.84M-12.21M3.6M3.63M10.91M8.56M8M3.16M-6.98M
Net Margin %2.45%-2.27%-0.09%0.81%2.15%6.23%-0.19%-0.38%2.5%1.59%2.64%2.66%6.67%3.17%2.78%0.93%-1.18%-3.89%5.9%7.13%-2.6%3.99%6.15%-7.17%2.2%2.39%8.78%8.07%7.9%3.19%-13.5%
Net Income Growth %173.93%-2395.91%-111.21%-64.38%-64.82%3252.59%45.17%-115.55%71.78%-39.93%-0.95%-59.81%148.47%34.83%232.32%182.02%68.92%-153.54%-18.85%381.45%-163.28%-26.69%156.03%-439.59%-0.96%-66.71%27.48%6.98%152.84%145.36%-174.21%
EPS (Diluted)0.23-0.23-0.030.060.190.56-0.02-0.030.200.110.190.190.480.180.120.02-0.05-0.180.250.33-0.150.180.25-0.560.100.120.460.370.350.09-0.37
EPS Growth %165.35%-724.37%-150.54%-70.95%-66.07%3031.94%44.96%-117.35%81.82%-42.11%0%-60.42%166.67%50%500%136.97%69.94%-172%-24.24%320%-183.33%-28%144.64%-660%-16.67%-73.91%24.32%5.71%288.89%124.32%-175.51%
EPS (Basic)--0.23-0.030.060.190.58-0.02-0.030.200.110.190.190.500.190.130.02-0.05-0.180.260.36-0.150.180.26-0.570.100.120.480.370.350.09-0.37
Diluted Shares Outstanding21.77M20.4M20.4M20.39M20.4M21.82M20.26M20.28M22.64M23.96M23.09M23.32M22.96M21.29M22.27M22.34M22.31M21.87M21.95M23.04M20.86M22.11M27.38M21.66M21.66M20.22M21.1M19.02M18.57M18.86M18.67M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Underwriting volatility in P&C

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q3)

Premium Growth Accelerates Amid Volatility

According to the most recent quarterly data, AAME achieved a 20.8% year-over-year revenue growth in 2025Q3, marking a significant departure from the stagnant or negative growth trends observed throughout 2024, which suggests a potential successful re-pricing strategy or expansion within their specialized municipal fleet insurance segments.

The sharp uptick in top-line performance warrants investigation into whether this is driven by sustainable rate increases or a temporary surge in policy acquisition. Investors should monitor if this growth trajectory can be maintained without further compromising the loss ratio, which has historically shown sensitivity to competitive pricing pressures.

Underwriting Profitability Remains Highly Variable

As reported in financial statements, the combined ratio fluctuated significantly from a peak of 106.6% in 2023Q4 to a more favorable 92.4% in 2025Q2, indicating that the company's core underwriting profitability remains highly sensitive to claim severity and the underlying mix of P&C and life products.

The volatility in the combined ratio suggests that AAME struggles to maintain consistent underwriting margins, often dipping into technical losses that necessitate reliance on investment income. The recent improvement in 2025 suggests a potential stabilization, yet the historical tendency for the ratio to breach the 100% threshold implies that underwriting discipline remains a primary concern for long-term margin expansion.

Reserve Adequacy Masks Operational Earnings Trends

Based on the provided quarterly figures, the loss ratio volatility—ranging from 65.3% to 96.6% over the last ten quarters—suggests that prior-year reserve development may be significantly impacting current earnings, potentially masking the true underlying performance of the Bankers Fidelity and American Southern underwriting segments.

The wide swings in loss ratios indicate that the company may be experiencing unpredictable claim development, particularly in long-tail liability lines. Analysts should scrutinize whether recent earnings improvements are driven by genuine underwriting efficiency or the release of reserves that were previously set aside for higher-than-expected claim costs.

Structural Challenges to Sustainable Profitability

Data from the last ten quarters indicates that AAME has frequently operated with a combined ratio exceeding 100%, which, as noted in industry filings, implies that the company is fundamentally dependent on investment income to offset core underwriting losses during periods of elevated claim activity.

The persistent inability to consistently generate underwriting profit suggests that the company's niche focus may not provide sufficient scale to absorb administrative and acquisition costs. Investors should remain cautious, as the reliance on investment returns to achieve net profitability leaves the bottom line vulnerable to broader market fluctuations and interest rate cycles.

AAME — Frequently Asked Questions

Quick answers to the most common questions about buying AAME stock.

What was Atlantic American Corporation's (AAME) revenue in 2024?

For fiscal year 2024, Atlantic American Corporation (AAME) reported total revenue of $188.2M. This represents a 264.3% increase compared to $51.7M in 1995.

Is Atlantic American Corporation (AAME) profitable?

Atlantic American Corporation (AAME) reported a net loss of $4.3M for the fiscal year ending 2024.

What is Atlantic American Corporation's operating profit margin?

Atlantic American Corporation (AAME) reported an operating income of $-5.3M, resulting in an operating profit margin of -2.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Atlantic American Corporation's gross profit and gross margin?

Atlantic American Corporation (AAME) generated $14.4M in gross profit for the year, representing a gross profit margin of 7.6%. This demonstrates the company's core pricing power and production efficiency.